Tumor-Derived Extracellular Vesicles: Their Role in Immune Cells and Immunotherapy
Authors:
Open Access
- 1 August 2021
- journal article
- review article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. ume 16, 5395-5409
Abstract
Nowadays, tumor has been the serious threat to human health and life. To further explore the mechanism of tumor genesis and development is necessarily for developing the effective treatment strategy. Extracellular vesicles are the vesicles secreted by almost all types of cells, and they play an important part in intercellular communication by transporting their cargoes. Immune cells are the vital components of the human defense system, which defense against infection and tumor through cytotoxicity, immune surveillance, and clearance. However, via release tumor-derived extracellular vesicles, tumor could induce immune cells dysfunction to facilitate its proliferation and metastasis. Studies have shown that tumor-derived extracellular vesicles play dual role on immune cells by their specific cargoes. Here, we reviewed the effects of tumor-derived extracellular vesicles on immune cells in recent years and also summarized their research progress in the tumor immunotherapy and diagnosis.Keywords
This publication has 96 references indexed in Scilit:
- Exosome derived from epigallocatechin gallate treated breast cancer cells suppresses tumor growth by inhibiting tumor-associated macrophage infiltration and M2 polarizationBMC Cancer, 2013
- MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory responseProceedings of the National Academy of Sciences, 2012
- Plasma exosomes can deliver exogenous short interfering RNA to monocytes and lymphocytesNucleic Acids Research, 2012
- Exosomes Released from Mycoplasma Infected Tumor Cells Activate Inhibitory B CellsPLOS ONE, 2012
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Cancer immunotherapy via dendritic cellsNature Reviews Cancer, 2012
- Blast-derived microvesicles in sera from patients with acute myeloid leukemia suppress natural killer cell function via membrane-associated transforming growth factor- 1Haematologica, 2011
- Thermal- and Oxidative Stress Causes Enhanced Release of NKG2D Ligand-Bearing Immunosuppressive Exosomes in Leukemia/Lymphoma T and B CellsPLOS ONE, 2011
- Natural Killer Cell Cytotoxicity Is Suppressed by Exposure to the Human NKG2D Ligand MICA*008 That Is Shed by Tumor Cells in ExosomesCancer Research, 2010
- Myeloid-derived suppressor cells as regulators of the immune systemNature Reviews Immunology, 2009